STEMI patients with diabetes show higher mortality following PCI

09/23/2013 | Healio

Diabetes patients who underwent percutaneous coronary intervention for STEMI had nearly four times the mortality rate of those without diabetes, according to results from the INFUSE-AMI trial. Researchers also found those with diabetes had more extensive left anterior descending artery disease and a higher 30-day revascularization rate compared with the nondiabetes cohort. The findings appear in the journal Catheterization and Cardiovascular Interventions.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA